Nath Bio-genes (india) Ltd Board of Directors
Board of Directors at Nath Bio-Genes (India) Ltd
Director
Independent Director
Company Sec. & Compli. Officer
Independent Director
Director
Key Highlights
- Satish Kagliwal continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Dhiraj Rathi continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
- Jeevanlata Kagliwal joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vadla Nagbhushanam continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Madhukar Deshpande joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Nath Bio-Genes (India) Ltd
NSE: NATHBIOGEN
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Feb 2026 | 152.6 |
| 05 Feb 2026 | 150.5 |
| 04 Feb 2026 | 150.5 |
| 03 Feb 2026 | 149 |
| 02 Feb 2026 | 148.9 |
| 01 Feb 2026 | 145.45 |
| 30 Jan 2026 | 145.35 |
| 29 Jan 2026 | 143.2 |
| 28 Jan 2026 | 141.8 |
| 27 Jan 2026 | 141.9 |
Company Fundamentals for Nath Bio-Genes (India) Ltd
Market Cap
290 Cr
EPS
20.5
P/E Ratio (TTM)
7.4
P/B Ratio (TTM)
0.4
Day’s High
155.65
Day’s Low
154.6
DTE
0.2
ROE
6.8
52 Week High
238.0
52 Week Low
138.0
ROCE
7.4
Market Price of Nath Bio-Genes (India) Ltd
1M
1Y
3Y
5Y
Nath Bio-Genes (India) Ltd News Hub
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024
Read more
07 Aug 24
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 20
Read more
17 Oct 24
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 202
Read more
23 Oct 24
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September
Read more
23 Oct 24
